Company · CIK 1885522

# Neumora Therapeutics, Inc.

| CIK | [1885522](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001885522) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | NMRA (Nasdaq) |
| First annual or quarterly report | 2023-11-01 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-282460 | Shelf Effective | 2024-10-01 | 2025-03-26 | 2 |
| 333-274229 | IPO Final prospectus | 2023-08-25 | 2023-09-18 | 4 |

## Filings

 7

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-03-26 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1885522/999999999525000791/9999999995-25-000791-index.htm) Declared effective | 333-282460 | 9999999995-25-000791 |
| 2024-10-01 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1885522/000119312524230348/0001193125-24-230348-index.htm) Shelf registered | 333-282460 | 0001193125-24-230348 |
| 2023-09-18 | [424B4](https://www.sec.gov/Archives/edgar/data/1885522/000119312523236920/0001193125-23-236920-index.htm) Final prospectus | 333-274229 | 0001193125-23-236920 |
| 2023-09-14 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1885522/999999999523002676/9999999995-23-002676-index.htm) Declared effective | 333-274229 | 9999999995-23-002676 |
| 2023-09-11 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1885522/000119312523231902/0001193125-23-231902-index.htm) Amendment | 333-274229 | 0001193125-23-231902 |
| 2023-08-25 | [S-1](https://www.sec.gov/Archives/edgar/data/1885522/000119312523221589/0001193125-23-221589-index.htm) Registration filed | 333-274229 | 0001193125-23-221589 |
| 2021-11-08 | [DRS](https://www.sec.gov/Archives/edgar/data/1885522/000095012321014224/0000950123-21-014224-index.htm) Draft made public | 377-05663 | 0000950123-21-014224 |

[All filings of this company](https://equitycapital.markets/filings?cik=1885522) · [CSV](https://equitycapital.markets/filings.csv?cik=1885522)

---
Source page: https://equitycapital.markets/company/1885522 · Data: U.S. SEC EDGAR · CC BY 4.0